N@N

Tessa Romero Maintained (YMAB) at Sell with Decreased Target to $7 on, Aug 22nd, 2023

Tessa Romero of JP Morgan, Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Sell with Decreased Target from $8 to $7 on, Aug 22nd, 2023.

Tessa has made no other calls on YMAB in the last 4 months.

There are 5 other peers that have a rating on YMAB. Out of the 5 peers that are also analyzing YMAB, 1 agrees with Tessa's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Alec Stranahan of "B of A Securities" Maintained at Hold with Increased Target to $12 on, Monday, May 15th, 2023

These are the ratings of the 4 analyists that currently disagree with Tessa

---

• Michael Ulz of "Morgan Stanley" Maintained at Sell with Decreased Target to $5 on, Monday, August 14th, 2023
• Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Monday, August 14th, 2023
• William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $22 on, Tuesday, July 25th, 2023
• David Nierengarten of "Wedbush" Upgraded from Hold to Buy and Increased Target to $13 on, Wednesday, May 10th, 2023

Contributing Sources

---